Translational & Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK
Sir John Burn is a Professor of Clinical Genetics at Newcastle University, a position he has held since 1991. Alongside his clinical and teaching duties, Professor Sir John Burn also serves as chief investigator of the Cancer Prevention Programme (CaPP), and leads the genetics arm of the UK National Institute of Health Research. The CaPP trials have provided vital insight into the role of aspirin in reducing the incidence of cancers in people who have a genetically predisposed increased risk of developing cancer. Professor Sir John Burn was knighted in 2010 in recognition of his services to medicine and healthcare.